Streptomyces noursei ATCC 11455 produces the antifungal polyene antibiotic nystatin containing the deoxysugar moiety mycosamine. Part of the deoxythymidyl diphosphate (TDP)-glucose dehydratase gene (gdhA) known to be involved in deoxysugar biosynthesis was amplified by PCR from genomic DNA of S. noursei ATCC 11455. A gene library for S. noursei was made and screened with the gdhA probe. Several overlapping phage clones covering about 30 kb of the S. noursei genome were physically mapped. A partial DNA sequencing analysis of this region resulted in the identification of several putative genes typical of macrolide antibiotic biosynthetic gene clusters. A gene-transfer system for S. noursei has been established, and gene deletion or disruption experiments within the putative biosynthetic gene cluster were performed. All of the knock-out mutants retained the ability to produce nystatin, suggesting that the identified gene cluster is not involved in biosynthesis of this antibiotic. Culture extracts from the wild-type strain and three knock-out mutants were analysed by TLC followed by a bioassay against Micrococcus luteus. Two antibacterial compounds were found to be synthesized by the wild-type strain while only one was produced by the mutants. This provided evidence for the involvement of the identified gene cluster in the biosynthesis of a presumably novel antibacterial macrolide antibiotic in S. noursei.
INTRODUCTION
Filamentous soil bacteria belonging to the genus Streptomyces are widely recognized as industrially important micro-organisms because of their ability to produce antibiotics. In the past few years there has been rapid progress in genetic characterization of the biosynthetic pathways for various antibiotics produced by these organisms (Schwecke et al., 1995 ; Katz & Donadio, 1995) . Knowledge acquired during these studies allows one to more or less precisely predict the order of biochemical reactions leading to the synthesis of a given antibiotic. Moreover, knowledge gained through the functional analysis of antibiotic biosynthesis genes gives an opportunity to manipulate the pathways in a rational manner in order to produce novel compounds with improved properties (Hopwood, 1997) .
A large number of antibiotics used in medical and veterinary care, and agriculture are of a polyketide origin. The polyketide backbone of these antibiotics is synthesized by polyketide synthase (PKS)-assisted condensation of the building units represented usually by acetyl-, propionyl-and (methyl)malonyl-CoA (Hopwood, 1997) . Both the sequential manner in which the backbone is assembled and the fact that specific domains within a PKS are responsible for a given biosynthetic step provides an excellent opportunity for protein engineering. Indeed, several research groups have reported successful manipulations of PKS genes which resulted in biosynthesis of new compounds (for example, Kuhstoss et al., 1996 ; Ruan et al., 1997) . However, the polyketide backbone by itself usually has little, if any, biological activity. Modifications of this backbone by means of hydroxylation, methylation, acylation and glycosylation are usually required for achieving full potency, and the genes providing these activities are often found in the proximity of the PKS genes (Katz & Donadio, 1995) . This fact further expands the possibilities for manipulations of the biosynthetic pathways, potentially leading to overproducing strains or new antibiotics (Sezonov et al., 1997 ; Solenberg et al., 1997) . We have initiated molecular genetic studies on Streptomyces noursei ATCC 11455, the producer of the antifungal polyene antibiotic nystatin. The latter is currently being used for the treatment of many fungal infections in humans. The structure of nystatin predicts the involvement of type I (modular) PKS enzymes in biosynthesis of its polyketide backbone, while a mycosamine moiety attached to the aglycone implies involvement of deoxysugar biosynthesis genes. Using a PCR-derived probe for the deoxythymidyl diphosphate (TDP)-glucose dehydratase gene, we have identified part of the gene cluster apparently governing the biosynthesis of a macrolide antibiotic. Gene disruption and replacement experiments showed that this gene cluster is not required for nystatin biosynthesis, but that it governs the synthesis of an antibacterial agent in S. noursei ATCC 11455.
METHODS
Bacterial strains, plasmids and phages. Bacterial strains, plasmids and phages used in this study are listed in Table 1 except for plasmids pKH10, pKH11, pKH12, pKH14, pKH15, pKH16 and pKH17. These plasmids were constructed by cloning the corresponding EcoRI KH fragments depicted in Fig. 1(a) into the EcoRI site of pGEM3Zf(k).
Media, growth conditions and transformation procedures. S. noursei ATCC 11455 and its mutants were grown on solid ISP2 medium (Difco) and in liquid TSB medium (Sigma). For preparation of protoplasts, cultures were grown at 30 mC for 40 h in TSB medium supplemented with 1n5 % glycine. S. noursei protoplasts were prepared and regenerated according to Hopwood et al. (1985) except that P medium contained 20 % sucrose and regeneration medium R5 contained 15 % sucrose. Streptomyces lividans 1326 protoplasts were obtained and transformed as described by Hopwood et al. (1985) . Intergeneric conjugation from Escherichia coli ET12567(pUZ8002) into Streptomyces strains was done as described by Flett et al. (1997) . E. coli strains were grown and transformed as described by Sambrook et al. (1989) except for E. coli ET12567(pUZ8002), which was maintained on media containing 20 µg chloramphenicol ml − " and 50 µg kanamycin ml − ". Micrococcus luteus ATCC 10240 was maintained essentially as E. coli strains except that the incubation temperature was 35 mC.
Molecular genetic techniques.
Plasmid, phage and total DNA preparations, endonuclease digestions, ligations and fractionation were performed as described previously (Sambrook et al., 1989 ; Hopwood et al., 1985) . Modification of plasmid DNA in vitro was done according to Matsushima & Baltz (1994) . DNA fragments were isolated from agarose gels using the Qiagen QIAEX kit, labelled by the use of the HighPrime kit from Boehringer Mannheim, and used for Southern blot analysis. PCR amplification of the gdh fragment was done according to Decker et al. (1996) . DNA sequencing reactions were performed with a DNA sequencing kit from Applied Biosystems and analysed with an automated DNA sequencer from the same supplier. DNA sequences were analysed using the GCG program package (Devereux et al., 1984) and deposited in GenBank.
Analysis of secondary metabolites. For nystatin production, S. noursei strains were grown for 120 h in 50 ml SAO- 28 mC (220 r.p.m.). Cells were then pelleted and extracted with DMSO, and extracts analysed by HPLC. For production of antibacterial compounds, S. noursei was grown for 120 h in 50 ml MP1 medium (g per l : glucose, 40 ; yeast extract, 1n5;
; CaCO $ , 3) in shake flasks at 28 mC (220 r.p.m.). Culture supernatants were then extracted with equal volumes of ethyl acetate, and extracts were evaporated under vacuum. The pellets were dissolved in small amounts of ethyl acetate and subjected to TLC analysis. TLC plates (Merck) were developed in ethyl acetate\methanol\water (100 : 2n5 : 1, by vol.). For antibacterial agent bioassay, TLC plates were placed for 30 min on the surface of LB agar plates inoculated with M. luteus ATCC 10240. The agar plates were then incubated for 16 h at 35 mC and screened visually for growth-inhibition zones.
RESULTS

Identification of a macrolide antibiotic biosynthesis gene cluster in S. noursei ATCC 11455
Several groups have reported the cloning of gene clusters for biosynthesis of antibiotics containing a deoxysugar moiety using a probe for the TDP-glucose dehydratase (gdh) gene, which governs one of the initial steps in deoxysugar formation (Liu & Thorson, 1994) . Since the nystatin molecule contains the deoxysugar mycosamine, we decided to use a similar approach to identify the nystatin biosynthesis gene cluster. Part of a presumptive gdh gene was amplified from the S. noursei chromosome by PCR with primers designed by Decker et al. (1996) . DNA sequence analysis of the 550 bp PCR product designated gdhA showed that it encodes a peptide with 41n6 % identity to the RfbB TDP-glucose dehydratase from Xanthomonas campestris ( Table 2) . Hybridization of the labelled gdhA probe under high stringency conditions with S. noursei chromosomal DNA digested with several restriction enzymes showed the presence of one copy of gdhA in the genome (data not shown). A S. noursei gene library was then prepared in the bacteriophage λ vector DASHII. Screening of this library with the gdhA probe allowed the isolation of several overlapping phage clones which were then aligned according to their physical maps and hybridization with gdhA. Next, an EcoRI and some BamHI DNA fragments from the identified region were subcloned in the pGEM3Zf(k) vector and subjected to partial DNA sequence analysis. This analysis revealed several putative genes typical of those governing the biosynthesis of polyketide-derived antibiotics (Table 2 ). In particular, (Olano et al., 1995) , aa 338-467 62n4 2 157 aa Streptomycin 6-kinase (Vogtli & Hutter, 1987) , aa 250-309 35n5 3 170 aa EryBV glycosyltransferase (Gaisser et al., 1997) , aa 28-189 52n9 4 117 aa Putative transposase (Kaluza et al., 1985) , aa 257-354 27n1 5 144 aa EryF hydroxylase (Weber et al., 1991) , aa 306-407 57n1 6 174 aa MycF O-methyltransferase (Inouye et al., 1994) , aa 70-223 71n2 7 115 aa SnoY (Ylihonko et al., 1996) , aa 1-114 28n2 gdhA 186 aa RfbB TDP-glucose dehydratase (Koplin et al., 1993) , aa 9-197 41n6 8 187 aa Deoxyhexose reductase (Gaisser et al., 1997) , aa 9-162 48n7 9
181 aa TDP-glucose dehydratase (Lombo et al., 1997) , aa 6-172 67n2 10 110 aa TDP-glucose synthase (Tsukioka et al., 1997) , aa 1-110 60n9 11 181 aa EryA2 PKS (Donadio et al., 1991) , aa 120-300 75n7
genes presumably encoding proteins homologous to an ABC (ATP-binding cassette) transporter (ORF1), glycosyltransferase (ORF3), putative transposase (ORF4), P450 hydroxylase (ORF5), O-methyltransferase (ORF6), deoxyhexose reductase (ORF8), a second TDPglucose dehydratase (ORF9), TDP-glucose synthase (ORF10) and type I PKS (ORF11) have been identified (see Fig. 1a for their locations).
Development of a gene-transfer system for S. noursei ATCC 11455
To specifically inactivate the genes within the identified cluster, a gene transfer system for S. noursei had to be established. Initial studies showed that the organism is resistant to high concentrations of thiostrepton ( 100 µg ml −" ), hygromycin ( 200 µg ml −" ), gentamicin ( 50 µg ml −" ) and erythromycin ( 100 µg ml −" ). S. noursei plated on agar media supplemented with neomycin ( 50 µg ml −" ), kanamycin ( 50 µg ml −" ) or viomycin ( 50 µg ml −" ) consistently gave some background growth. However, S. noursei was sensitive to apramycin at concentrations 30 µg ml −" so this antibiotic was chosen for selection of transformants. Although a method for efficient protoplast formation and regeneration for S. noursei ATCC 11455 was established (see Methods), all our attempts to achieve S. noursei protoplast transformation with vectors pKC1218 and pSET152 using both standard and modified techniques failed. To extend the choice of vectors, the new plasmids pSOK101 (pIJ101 replicon), pSOK201 (pSG5 replicon) and pCHZ101 (pHZ1351 replicon) were constructed (see Fig. 2 and Table 1 ). However, transformation of S. noursei protoplasts with the above vectors failed to give any transformants. All five plasmids used in these transformation experiments contain the origin of transfer, oriT, from plasmid RP4 allowing mobilization of the construct during conjugation from an appropriate E. coli strain into Streptomyces sp. (Mazodier et al., 1989) . The plasmids could easily be introduced into S. lividans 1326 via both protoplast transformation and conjugation from E. coli ET12567(pUZ8002). Conjugation experiments with S. noursei (Table 3 ) using pSOK101, pKC1218 and pCHZ101 were unsuccessful. For pSOK201, a relatively high number of small apramycin-resistant colonies appeared on the conjugation plates. However, these putative transconjugants stopped growing after 3-4 d incubation and did not develop into normal colonies. Attempts to transfer these small colonies to fresh selective media resulted in slow-growing and poorly sporulating colonies from which no plasmid DNA could be isolated. About 1-2 colonies per plate were isolated when plasmid pSET152 carrying the site-specific integration system from streptomycete phage φC31 was used for conjugation. Southern blot analysis of two such S. noursei (pSET152) clones with labelled pSET152 DNA indicated integration of the plasmid into a specific site on the chromosome (data not shown).
Gene replacements and disruption within the identified gene cluster
The successful introduction of pSET152 into S. noursei ATCC 11455 provided evidence for intergeneric conjugation being the only tool for gene transfer into this organism. To test the possible involvement of the ORFs within the identified gene cluster in nystatin biosynthesis, gene-inactivation experiments were carried out. For this purpose, the suicide vector pRN4 was constructed by cloning, in the original orientation, a 1n6 kb EcoRI-BamHI fragment from pKH11 and a 1n35 kb BamHI-SalI fragment from pKH12 (SalI site not shown on the map) into a suicide vector carrying oriT and an apramycin-resistance gene (see Fig. 1a and Table  1 ). S. noursei ATCC 11455 transconjugants carrying pRN4 integrated into the chromosome via a singlecrossover event were obtained at a frequency four times higher than that found for the site-specific integration of pSET152. One of the transconjugants was allowed three rounds of sporulation on ISP2 agar without antibiotic selection and its progeny were screened for loss of the apramycin-resistance marker. Four such clones were selected and two of them, RN412 and RN413, were shown by hybridization of the labelled KH10 DNA fragment with their total DNA to contain the desired deletion (Fig. 3) . As shown in Fig. 1(b) , the above mutants have deletions of approximately 10n6 kb, affecting ORF5, ORF6, ORF7, gdhA and ORF8. ORF9, presumably encoding the second TDP-glucose dehydratase, was inactivated by gene replacement with pRN8. The latter was made by cloning the 1n4 kb BamHI-EcoRI fragment from pKH12, a 1n3 kb EcoRI kanamycin-resistance fragment and a 1n4 kb EcoRI-SphI fragment from pKH16 in a mobilizable suicide vector (see Fig. 1a and Table 1 ). The ORF9 gene replacement procedure was followed as above except that it was Macrolide antibiotic gene cluster in S. noursei performed in S. noursei strain RN413. In three recombinant strains, designated RN803, RN805 and RN807, ORF9 replacement was confirmed by Southern blot analysis (data not shown).
Finally, inactivation of ORF11, presumably encoding a type I PKS enzyme in S. noursei ATCC 11455, was made by gene disruption with pND2. pND2 was constructed by cloning the internal 1n3 kb BamHI-EcoRI fragment of ORF11 from KH16 into a mobilizable suicide vector (see Fig. 1a and Table 1 ). Integration of pND2 into the chromosome via a single crossover upon intergeneric conjugation resulted in strains ND21 and ND22. The integration of pND2 in these strains was also confirmed by Southern blot analysis of their total DNA (data not shown). The genotypes of all the recombinant strains constructed are presented in Fig. 1(b) .
Analysis of secondary metabolites produced by the wild-type strain and knock-out mutants S. noursei strains RN413, RN803 and ND21 were tested for nystatin production by shake flask experiments in the semi-defined medium SAO-23. All the mutants constructed produced nystatin in amounts similar to the wild-type (WT) strain ATCC 11455. Thus, it was concluded that the identified gene cluster is not involved in the biosynthesis of nystatin. From the information we had on the putative genes within the cluster, it was logical to assume that the cluster governs the biosynthesis of some macrolide antibiotic which is exported out of the cell (presence of gene for a putative ABC transporter). Thus, we focused our attempts on isolation of this unknown antibiotic. The shake flask fermentations were carried out with the mutant and the WT strains in the semi-defined medium MP1. Ethyl acetate extracts of the supernatants from 120 h cultures were analysed by TLC followed by a bioassay against M. luteus ATCC 10240. A large growth inhibition zone corresponding to the TLC spot with R F 0n44 (A) was observed in the case of the WT strain (Fig. 4) , while none of the mutants displayed a similar inhibition zone. We thus concluded that this zone corresponds to the compound (A) synthesized by the products of the putative genes within the identified gene cluster. In addition, the extracts from all strains contained another compound with antibacterial activity, as small inhibition zones corresponding to TLC spots with R F 0n12 (B) were also observed (Fig. 4) . Thus, the WT strain is capable of producing at least two antibacterial compounds, A and B, while the mutants fail to produce A due to the specific mutations within its biosynthetic gene cluster.
DISCUSSION
Using a PCR-amplified DNA probe for the putative TDP-glucose dehydratase gene we have isolated a 30 kb genomic region from S. noursei ATCC 11455, the producer of the antifungal antibiotic nystatin. A partial DNA sequencing analysis within the cloned segment revealed the presence of several ORFs presumably encoding homologues of the proteins involved in biosynthesis of, and resistance to, antibiotics in different streptomycetes. Establishment of a gene-transfer system for S. noursei allowed gene-inactivation experiments, which demonstrated that the identified gene cluster is not responsible for nystatin biosynthesis. However, by comparing the biological activities in culture supernatants of the WT strain and its constructed mutants, we were able to demonstrate the involvement of this gene cluster in the biosynthesis of a presumably novel antibacterial compound.
We speculate that this new compound is a macrolide antibiotic on the basis of the observed absence of the specific antibacterial activity in the mutant ND21 with disrupted ORF11, presumably encoding a type I PKS.
Sequence comparisons also suggest that the polyketide backbone of this compound might be modified by the means of hydroxylation (ORF5) and O-methylation (ORF6) during antibiotic synthesis. Five of the ORFs found within the cluster appear to be responsible for synthesis (gdhA, ORF8, ORF9 and ORF10) and attachment (ORF3) of deoxysugar(s) to the macrolide antibiotic precursor(s). It thus seems likely that at least one deoxysugar is attached to the polyketide moiety. Interestingly, two putative genes, gdhA and ORF9, both presumably encoding Gdh, are present in this cluster. It is possible that the two putative gdh genes are responsible for synthesis of two different deoxysugars, even though to our knowledge there is no precedent for finding two gdh genes within one cluster. Alternatively, one of the identified gdh genes may not encode a true dehydratase, but another as yet undescribed enzyme involved in deoxysugar formation. The modifications of the polyketide moiety seem to be crucial for the antibiotic activity, as a deletion affecting ORFs 5-8 and gdhA abolishes the specific antibacterial activity in mutant RN413. However, due to the limited DNA sequence data, we cannot exclude the possibility of a regulatory gene being affected by the deletion.
The two ORFs found within the cluster might be responsible for the resistance of S. noursei to the macrolide antibiotic identified. ORF1 seems to encode an ABC transporter homologous to the Streptomyces antibioticus OleB ATP-binding protein involved in the efflux of oleandomycin from the producing organism (Olano et al., 1995) . Another putative resistance gene might be represented by ORF2, which displays similarity to the Streptomyces glaucescens streptomycin 6-kinase responsible for the inactivation of streptomycin by means of its phosphorylation (Vogtli & Hutter, 1987) .
Finally, the putative ORF4 product resembles transposases from the Rhizobium japonicum insertion element (Kaluza et al., 1985) and insertion elements from some other bacteria. There is at least one other reported case of an insertion element being present in the antibiotic biosynthesis gene cluster ; IS1136 was found between the PKS-encoding genes in the erythromycin biosynthesis gene cluster of Saccharopolyspora erythraea (Donadio & Staver, 1993) .
So far, the production of two antifungal antibiotics of polyketide origin by S. noursei, cycloheximide and nystatin, had been documented (Roszkowski et al., 1972) . Although Brown & Hazen (1953) reported isolation of the antibacterial antibiotic phalamycin from a spontaneously obtained morphological variant of S. noursei, this strain was apparently a nystatin nonproducer and phalamycin was not produced by the wildtype S. noursei. Thus, it is not clear whether the phalamycin-producing strain was really S. noursei. We therefore suggest that the antibacterial compound identified in this study and the putative genes for its biosynthesis are novel. Further characterization of this antibiotic aimed at its purification, and elucidation of its chemical structure and potency, is under way.
